13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 41 holding rows worth $254,009,000.
- Accession
- 0001826434-22-000002
- Filer
- CIK 1826434
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 41 entries on the cover page, a total value of $254,009,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $254,009,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AbbVie,Inc. | 00287Y109 | COM | 179,950 | $24,365,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 78,528 | $21,691,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 147,396 | $19,095,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 48,347 | $16,931,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 436,300 | $15,886,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 318,269 | $15,048,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 732,515 | $12,248,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 506,280 | $12,232,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 313,929 | $10,736,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 583,402 | $10,204,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 45,904 | $9,919,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 213,174 | $9,309,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 59,940 | $9,267,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 142,032 | $8,310,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 975,933 | $7,856,000 | thousands by filing date | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 225,097 | $6,228,000 | thousands by filing date | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 226,700 | $5,089,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 89,840 | $4,187,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 1,578,947 | $3,616,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 271,159 | $3,381,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 24,346 | $3,355,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 23,700 | $3,034,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 23,632 | $1,987,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 5,169 | $1,857,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 74,000 | $1,788,000 | thousands by filing date | call |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 48,141 | $1,768,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 169,786 | $1,623,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 33,379 | $1,521,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 10,600 | $1,517,000 | thousands by filing date | call |
| 1LIFE HEALTHCARE INC | 68269G107 | COM | 84,748 | $1,489,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 26,177 | $1,370,000 | thousands by filing date | |
| AMERICAN WELL CORP | 03044L105 | CL A | 224,876 | $1,358,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 141,508 | $1,261,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 30,000 | $1,256,000 | thousands by filing date | put |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 40,571 | $1,008,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 55,433 | $806,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 25,043 | $782,000 | thousands by filing date | |
| FEMASYS INC | 31447E105 | cs | 145,631 | $568,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 26,387 | $26,000 | thousands by filing date | |
| ASPIRA WOMENS HEALTH INC | 04537Y109 | COM | 10,876 | $19,000 | thousands by filing date | |
| ATHERSYS INC | 04744L106 | COM | 19,449 | $18,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-22-000002 | this filing | 2022-02-14 | acceptance time not in the bulk data set |